Drug Markets/Bumetanide

Bumetanide

58 NDCs across 15 manufacturers|58 Generic,0 Brand

Bumetanide is used to treat acute kidney injury, ascites, edema, heart failure, hypertension and chronic kidney failure, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Feb 28, 1983, and the first generic was approved Oct 31, 1994. FDA's Orange Book lists 39 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $79 million on Bumetanide across 2.4 million claims for 571,000 beneficiaries.

Bumetanide is available as 58 NDCs from 15 manufacturers (58 generic, 0 brand), with NADAC prices from $0.11 to $0.24 per EA — the most expensive product costs about 2.3× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

58

58G / 0B

Manufacturers

15

competing in market

Price Spread

$0.11 – $0.24

per EA

7d Activity

48↑10 flat

avg +4.7% WoW · of 58 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

58 NDCs total, 58 shown

WatchDrug ↕Price 7d Change ↕
BUMETANIDE 2 MG TABLET
$0.2436
per EA
—
BUMETANIDE 2 MG TABLET
$0.2357
per EA
—
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1974
per EA
+6.39%
BUMETANIDE 2 MG TABLET
$0.1819
per EA
—
BUMETANIDE 2 MG TABLET
$0.1767
per EA
—
BUMETANIDE 2 MG TABLET
$0.1767
per EA
—
BUMETANIDE 1 MG TABLET
$0.1585
per EA
—
BUMETANIDE 1 MG TABLET
$0.1585
per EA
—
BUMETANIDE 0.5 MG TABLET
$0.1430
per EA
+7.38%
BUMETANIDE 0.5 MG TABLET
$0.1430
per EA
+7.38%
BUMETANIDE 0.5 MG TABLET
$0.1430
per EA
+7.38%
BUMETANIDE 0.5 MG TABLET
$0.1430
per EA
+7.38%
BUMETANIDE 0.5 MG TABLET
$0.1430
per EA
+7.38%
BUMETANIDE 0.5 MG TABLET
$0.1430
per EA
+7.38%
BUMETANIDE 0.5 MG TABLET
$0.1430
per EA
+7.38%
BUMETANIDE 0.5 MG TABLET
$0.1430
per EA
+7.38%
BUMETANIDE 0.5 MG TABLET
$0.1430
per EA
+7.38%
BUMETANIDE 0.5 MG TABLET
$0.1430
per EA
+7.38%
BUMETANIDE 0.5 MG TABLET
$0.1356
per EA
—
BUMETANIDE 0.5 MG TABLET
$0.1265
per EA
—
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1137
per EA
+2.04%
BUMETANIDE 1 MG TABLET
$0.1079
per EA
—

Frequently Asked Questions

What is Bumetanide used to treat?

Bumetanide is used to treat acute kidney injury, ascites, edema, heart failure, hypertension and chronic kidney failure, per the National Library of Medicine's MED-RT classification.

When did Bumetanide become available as a generic?

FDA approved the first generic Bumetanide (ANDA) on Oct 31, 1994. The Orange Book currently lists 39 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Bumetanide?

In 2024, Medicare Part D spent $79 million on Bumetanide across 2.4 million claims for 571,000 beneficiaries.

How many Bumetanide products are on the market?

The Bumetanide drug market contains 58 NDCs from 15 manufacturers — 58 generic and 0 brand products.

What is the price range for Bumetanide?

NADAC reference prices for Bumetanide range from $0.1079 to $0.2436 per EA — the most expensive product costs about 2.3× the cheapest.

Which manufacturers make Bumetanide?

15 manufacturers list Bumetanide in NADAC. Ranked by number of NDCs, the largest are Sandoz Inc. (6), Zydus Pharmaceuticals (USA) Inc. (5), Solco Healthcare US LLC (5), Edenbridge Pharmaceuticals LLC (5), Amneal Pharmaceuticals NY LLC (5).

How has the price of Bumetanide changed recently?

Over the past 7 days, 48 Bumetanide NDCs rose and 0 fell, with a market-wide average change of +4.7%.